Prof Mariana Brandão, medical oncologist at Institute Jules Bordet, Hôpital Universitaire de Bruxelles presents a phase I/IIa study that aims to investigate the efficacy and safety of dry powder inhaled cisplatin in stage IV NSCLC patients.

With the educational support of:

You may also be interested in:

Updated safety data of AEGEAN study

Immunotherapy in the peri-operative treatment of patients with early-stage NSCLC

ELCC 2024 Daily highlight 1

Tags:

poster